Literature DB >> 20529130

The neurobiology of amyotrophic lateral sclerosis.

André Bento-Abreu1, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht.   

Abstract

Amyotrophic lateral sclerosis is a degenerative disease affecting the motor neurons. In spite of our growing insights into its biology, it remains a lethal condition. The identification of the cause of several of the familial forms of ALS allowed generation of models to study this disease both in vitro and in vivo. Here, we summarize what is known about the pathogenic mechanisms of ALS induced by hereditary mutations, and attempt to identify the relevance of these findings for understanding the pathogenic mechanisms of the sporadic form of this disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20529130     DOI: 10.1111/j.1460-9568.2010.07260.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  33 in total

1.  The preclinical discovery of amyotrophic lateral sclerosis drugs.

Authors:  Marcie A Glicksman
Journal:  Expert Opin Drug Discov       Date:  2011-10-25       Impact factor: 6.098

2.  Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration.

Authors:  Sebastian A Lewandowski; Ingrid Nilsson; Linda Fredriksson; Peter Lönnerberg; Lars Muhl; Manuel Zeitelhofer; Milena Z Adzemovic; Susanne Nichterwitz; Daniel A Lawrence; Eva Hedlund; Ulf Eriksson
Journal:  Acta Neuropathol       Date:  2015-12-19       Impact factor: 17.088

Review 3.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

4.  Axonal transport deficits and degeneration can evolve independently in mouse models of amyotrophic lateral sclerosis.

Authors:  Petar Marinkovic; Miriam S Reuter; Monika S Brill; Leanne Godinho; Martin Kerschensteiner; Thomas Misgeld
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

5.  The benefits and limitations of animal models for translational research in neurodegenerative diseases.

Authors:  Mathias Jucker
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

6.  Early pathogenesis in the adult-onset neurodegenerative disease amyotrophic lateral sclerosis.

Authors:  Brigitte van Zundert; Pamela Izaurieta; Elsa Fritz; Francisco J Alvarez
Journal:  J Cell Biochem       Date:  2012-11       Impact factor: 4.429

7.  Expression of the ALS-causing variant hSOD1(G93A) leads to an impaired integrity and altered regulation of claudin-5 expression in an in vitro blood-spinal cord barrier model.

Authors:  Sabrina Meister; Steffen E Storck; Erik Hameister; Christian Behl; Sascha Weggen; Albrecht M Clement; Claus U Pietrzik
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-08       Impact factor: 6.200

8.  Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability.

Authors:  Elsa Fritz; Pamela Izaurieta; Alexandra Weiss; Franco R Mir; Patricio Rojas; David Gonzalez; Fabiola Rojas; Robert H Brown; Rodolfo Madrid; Brigitte van Zundert
Journal:  J Neurophysiol       Date:  2013-03-13       Impact factor: 2.714

9.  The Neurotoxic TAU45-230 Fragment Accumulates in Upper and Lower Motor Neurons in Amyotrophic Lateral Sclerosis Subjects.

Authors:  Claudia R Vintilescu; Sana Afreen; Ashlee E Rubino; Adriana Ferreira
Journal:  Mol Med       Date:  2016-08-03       Impact factor: 6.354

10.  Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats.

Authors:  Cao Huang; Jianbin Tong; Fangfang Bi; Qinxue Wu; Bo Huang; Hongxia Zhou; Xu-Gang Xia
Journal:  Hum Mol Genet       Date:  2012-07-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.